A detailed history of State Of New Jersey Common Pension Fund D transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 77,880 shares of BEAM stock, worth $1.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
77,880
Previous 84,061 7.35%
Holding current value
$1.8 Million
Previous $2.29 Million 12.46%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$23.46 - $45.07 $145,006 - $278,577
-6,181 Reduced 7.35%
77,880 $2.57 Million
Q4 2023

Feb 02, 2024

SELL
$17.69 - $30.76 $392,859 - $683,118
-22,208 Reduced 20.9%
84,061 $2.29 Million
Q3 2023

Nov 08, 2023

BUY
$23.01 - $32.46 $717,106 - $1.01 Million
31,165 Added 41.5%
106,269 $2.56 Million
Q2 2023

Aug 02, 2023

BUY
$29.32 - $35.99 $534,562 - $656,169
18,232 Added 32.06%
75,104 $2.4 Million
Q1 2023

Apr 26, 2023

BUY
$30.15 - $48.79 $177,945 - $287,958
5,902 Added 11.58%
56,872 $1.74 Million
Q4 2022

Feb 01, 2023

BUY
$36.73 - $51.6 $426,912 - $599,746
11,623 Added 29.54%
50,970 $1.99 Million
Q3 2022

Oct 28, 2022

SELL
$39.79 - $70.31 $1 Million - $1.77 Million
-25,209 Reduced 39.05%
39,347 $1.87 Million
Q2 2022

Aug 04, 2022

BUY
$29.86 - $62.36 $769,193 - $1.61 Million
25,760 Added 66.4%
64,556 $2.5 Million
Q1 2022

May 03, 2022

BUY
$53.73 - $82.16 $402,330 - $615,214
7,488 Added 23.92%
38,796 $2.22 Million
Q4 2021

Jan 31, 2022

BUY
$68.02 - $99.06 $298,063 - $434,080
4,382 Added 16.27%
31,308 $2.5 Million
Q3 2021

Oct 27, 2021

SELL
$84.37 - $133.6 $591,602 - $936,803
-7,012 Reduced 20.66%
26,926 $2.34 Million
Q2 2021

Jul 23, 2021

BUY
$64.12 - $128.71 $756,744 - $1.52 Million
11,802 Added 53.32%
33,938 $4.37 Million
Q1 2021

Apr 27, 2021

BUY
$71.28 - $120.75 $1.58 Million - $2.67 Million
22,136 New
22,136 $1.77 Million

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.62B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.